An Aspirin a Day Can Take the Eyesight Away

Medical doctors have proclaimed the benefits of an aspirin a day for the cardiovascular system. Dr. J G Moellendorf, DC, ND, LCP discusses recent research from the optometry profession about the risk of prolonged aspirin use on eyesight.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Regular aspirin use was significantly associated with an increased incidence of neovascular AMD (age-related macular degeneration).

Sturgeon Bay, WI (PRWEB) April 29, 2013

Sturgeon Bay, Wisconsin Chiropractor and Naturopath, Dr. J G Moellendorf, DC, ND, LCP notes that aspirin is one of the most commonly used drugs, with over 100 billion tablets consumed worldwide yearly. In 2007, the Agency for Healthcare Research and Quality noted that 19.3% of American adults use aspirin, with usage increasing with age. Aspirin is most generally used for pain relief from arthritis and rheumatologic diseases, and for its assumed cardioprotective effects. Optometrists and ophthalmologists are especially concerned about aspirin’s relationship to age-related macular degeneration, the leading cause of blindness as people get older.

Barbara Klein’s research team at the Department of Ophthalmology and Visual Sciences, University of Wisconsin (Madison) School of Medicine and Public Health studied this relationship. Their findings titled Long-Term Use of Aspirin and Age-Related Macular Degeneration were published in the December 2012 Journal of the American Medical Association.

Klein and her colleagues performed a longitudinal population-based study of age-related eye diseases in Beaver Dam, Wisconsin. Eye examinations were performed every 5 years over a 20 year period (1988-1990 through 2008-2010) and the occurrence of any age-related macular degeneration (AMD) was noted. All cases of AMD were broken down into four types: Early AMD, Late AMD, and the subtypes of Late AMD—Neovascular AMD and Pure Geographic Atrophy. The 4926 participants, aged 43 to 86 at the beginning of the study, were asked if they used aspirin at least twice weekly for longer than 3 months.

Over the course of the study, 512 cases of Early AMD were found in 2379 participants who were at risk, and 117 cases of Late AMD were found in 3132 participants that were at risk. Of those participants who used aspirin regularly 10 years prior to their exam, 1.76% showed Late AMD while non-aspirin users showed only a 1.03% incidence. Those with regular aspirin use 10 years prior had an increased incidence of Neovascular AMD but not Pure Geographic Atrophy. There was no effect on the incidence of Early AMD among those who had regularly used aspirin 5 or 10 years previous to their exam.

Klein and her fellow researchers state: “Our findings are consistent with a small but statistically significant association between regular aspirin use and incidence of Neovascular AMD.” This “small association” works out to a 71% overall increased incidence in macular degeneration.

More startling were the results of the research team led by Gerald Liew at the Center for Vision Research, Westmead Millennium Institute for Medical Research, at the University of Sydney (Australia). They published a paper titled: The Association of Aspirin Use With Age-Related Macular Degeneration in the February 2013 issue of the Journal of the American Medical Association Internal Medicine.

Liew and associates conducted a prospective analysis of data from the Blue Mountains Eye Study in Australia. Four eye exams were performed over a 15-year period (1992-1994 to 2007-2009). It was found that 257 of the 2389 participants (10.8%) were regular aspirin users. Over the 15 years of the study, 63 individuals (24.5%) developed Neovascular AMD. Of the non-regular aspirin users, Neovascular AMD was found in 0.8% at 5 years, 1.6% at 10 years, and 3.7% at 15 years. The rate in regular aspirin users was 1.9% at 5 years, 7.0% at 10 years, and 9.3% at 15 years, or about 2.5 times more likely to develop Neovascular AMD overall.

Liew and his co-authors concluded: “Regular aspirin use was significantly associated with an increased incidence of neovascular AMD.”

Dr. J G Moellendorf, DC, ND, LCP states, “While an aspirin a day for the heart may have some benefits (which many researchers are questioning), an aspirin a day can take the eyesight away. Rather than attempting to treat the inflammatory basis of arthritic and rheumatoid pains and cardiovascular diseases with aspirin and other NSAIDs, doctors should focus on the causes of the inflammation. There are many natural alternatives with fewer side effects, such as a gluten free diet for those sensitive, joint manipulation for misaligned joints, an alkaline diet such as the Paleolithic diet, and an increased consumption of omega 3 fatty acids and vitamin D for their inflammation reducing qualities.”

Additional information about Chiropractic, Naturopathy, and other forms of natural health care has been provided by Moellendorf Chiropractic Office, Ltd. at http://www.all-about-wellness.com. Using the latest research findings, Moellendorf Chiropractic Office, Ltd. uses a comprehensive package of Chiropractic care, decompression traction therapy, active therapeutic movement training, cold laser therapy, and natural nutrition for the natural treatment of neurological conditions and pain without drugs or surgery.

About: Dr. J G Moellendorf, DC, ND, LCP
Dr. J G Moellendorf, DC, ND, LCP attended the University of Wisconsin—Superior where he majored in Physics and Mathematics, with a minor in art photography. While attending the University of Minnesota—Minneapolis, he assisted in research on ribosomal proteins. Completing his Chiropractic studies at Palmer College of Chiropractic in Davenport, Iowa, he graduated Cum Laude (with high honors) in 1983. He started Moellendorf Chiropractic Office, Ltd. in Sturgeon Bay, Wisconsin in 1983. In 1996, Dr. Moellendorf was awarded his Doctorate in Naturopathy from Trinity School of Natural Health. In 2001, he received Chiropractic’s most prestigious award, the honorary Legion of Chiropractic Philosophers degree, for his thesis “The Workings of Innate Intelligence in Obsessive/Compulsive and Addictive Behaviors.” This paper was chosen for publishing in the book Philosophic Contemplations vol. 2 in 2002. In June of 2012, Dr. Moellendorf authored his first book titled Healthcare’s Best Kept Secret which can be ordered on Amazon. Dr. Moellendorf can be contacted by phone (920) 493-2126, fax (920) 743-1145, email jgmoellendorf(at)itol(dot)com, his website at http://www.all-about-wellness.com, or send a carrier pigeon to 44.84722N and 87.36416W.


Contact